您当前的位置:
首页 >
文章列表页 >
Clinical observation of dupilumab in the treatment of severe asthma-COPD overlap
更新时间:2025-11-04
    • Clinical observation of dupilumab in the treatment of severe asthma-COPD overlap

    • “Research from the Third People's Hospital of Nantong City shows that the combination of Dupilumab and conventional treatment can significantly improve symptoms, lung function, and quality of life in patients with severe bronchial asthma chronic obstructive pulmonary disease overlap, reduce biomarker levels, and have good safety.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 20, Pages: 2571-2576(2025)
    • DOI:10.6039/j.issn.1001-0408.2025.20.15    

      CLC: R974;R969.4
    • Received:10 April 2025,

      Revised:2025-08-28,

      Accepted:03 September 2025,

      Published:30 October 2025

    移动端阅览

  • JI Honghua,JI Wangfei,ZHU Qilin.Clinical observation of dupilumab in the treatment of severe asthma-COPD overlap[J].ZHONGGUO YAOFANG,2025,36(20):2571-2576. DOI: 10.6039/j.issn.1001-0408.2025.20.15.

  •  
  •  

0

Views

24

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Advances in the clinical application and safety of bispecific antibodies for cancer therapy
Clinical observation of Huangkui capsule combined with cyclophosphamide and prednisone in the treatment of IgA nephropathy with renal insufficiency
Efficacy and safety of ruxolitinib in the treatment of myelofibrosis
Overview of systematic evaluation of anti-VEGF drugs in the treatment of diabetic macular oedema
Clinical observation of pramipexole combined with levodopa-benserazide in the treatment of Parkinson’s disease

Related Author

LIN Mengmeng
LIN Xu
WANG Yixuan
JIANG Danna
SHI Shanshan
LI Yangling
JIANG Yan
ZHANG Ming

Related Institution

School of Pharmaceutical Sciences, Wenzhou Medical University
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University
Dept. of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine
Dept. of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University
Dept. of Pharmacy, the Second Affiliated Hospital of Dalian Medical University
0